Pacific Biosciences Of Stock In The News
| PACB Stock | USD 1.85 0.37 25.00% |
Our overall analysis of Pacific Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Pacific Biosciences of. The specific impact of Pacific Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Pacific Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pacific Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Pacific Biosciences Backtesting and Pacific Biosciences Hype Analysis.
Pacific |
Pacific Biosciences Today Top News and Investor Outlook
Pacific Biosciences of Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pacific and other traded companies coverage with news coverage. We help investors stay connected with Pacific headlines for the 17th of February 2025 to make an informed investment decision based on correlating the impacts of news items on Pacific Stock performance. Please note that trading solely based on the Pacific Biosciences of hype is not for everyone as timely availability and quick action are needed to avoid losses.
Pacific Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pacific earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Pacific Biosciences that are available to investors today. That information is available publicly through Pacific media outlets and privately through word of mouth or via Pacific internal channels. However, regardless of the origin, that massive amount of Pacific data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pacific Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pacific Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pacific Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pacific Biosciences alpha.
Pacific Largest EPS Surprises
Earnings surprises can significantly impact Pacific Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-02-01 | 2017-12-31 | -0.2 | -0.18 | 0.02 | 10 | ||
2015-08-05 | 2015-06-30 | -0.14 | -0.16 | -0.02 | 14 | ||
2025-02-13 | 2024-12-31 | -0.1732 | -0.2 | -0.0268 | 15 | ||
2022-02-15 | 2021-12-31 | -0.28 | -0.31 | -0.03 | 10 | ||
2020-08-03 | 2020-06-30 | -0.18 | -0.15 | 0.03 | 16 | ||
2014-10-23 | 2014-09-30 | -0.16 | -0.13 | 0.03 | 18 |
Pacific Biosciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pacific Biosciences Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
14th of February 2025
Pacific Biosciences of California Inc Q4 2024 Earnings Call Highlights Navigating ... at gurufocus.com
13th of February 2025
How Has Institutional Trading Impacted Pacific Biosciences at kalkinemedia.com
12th of February 2025
Pacific Biosciences of California Inc Q4 2024 Earnings Report Preview What To Expect at finance.yahoo.com
7th of February 2025
Sequencing Reagents Industry Eyes 15.84 Billion Valuation by 2030 - Thermo Fisher Scientif... at globenewswire.com
4th of February 2025
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Techno... at businesswire.com
3rd of February 2025
PacBio Announces Appointment of David Ruggiero as Head of Global Sales Service at globenewswire.com
31st of January 2025
Genomics Market to Grow by USD 5.21 Billion , Boosted by Rising Investments in RD, with AI... at finance.yahoo.com
29th of January 2025
Revolutionary DNA Tech Cracks Medical Mystery That Stumped Traditional Testing - StockTita... at news.google.com
23rd of January 2025
Acquisition by Ordonez Kathy of 32179 shares of Pacific Biosciences at 1.65 subject to Rul... at Ordonez Kathy
15th of January 2025
Dont Ignore The Insider Selling In Pacific Biosciences of California at simplywall.st
27th of December 2024
Disposition of 25000 shares by Mohr Marshall of Pacific Biosciences at 4.45 subject to Rul... at Mohr Marshall
6th of December 2024
Pacific Biosciences Appoints CEO as Interim CFO - TipRanks at news.google.com
Pacific Biosciences Investors Sentiment
The influence of Pacific Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pacific. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacific Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacific Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pacific Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pacific Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pacific Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pacific Biosciences' short interest history, or implied volatility extrapolated from Pacific Biosciences options trading.
Check out Pacific Biosciences Backtesting and Pacific Biosciences Hype Analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.58) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.